AI Pocket-Based Design Yields a Potent STAT3 Inhibitor for Colorectal Cancer
- A pocket-conditioned, autoregressive generative AI model was used to design candidate molecules directly within the STAT3 binding pocket, rather than screening pre-existing compound libraries.
- This structure-based generative approach produced a potent small-molecule STAT3 inhibitor that advanced to biological evaluation.
- The inhibitor showed activity against colorectal cancer, where STAT3 hyperactivation is a recognized driver of tumor growth and survival.
💡 Points
STAT3's SH2 dimerization pocket is shallow and dynamic — the reason most inhibitor programs (niclosamide analogs, peptidomimetics) never reached clinic. Generating atoms directly inside that pocket geometry, rather than rescoring a static virtual library, is the real methodological jump here. Still, "potent" on paper means little until we see SH2 selectivity over STAT1/5 and a synthesizable route — that's where de novo hits usually stall.